Hyderabad: The National Institutes of Health (NIH) has issued treatment guidelines for the novel coronavirus (COVID-19).
The guidelines are developed by a panel of U.S. physicians, statisticians, and other experts.
The guidelines are issued for health care providers and are based on published and preliminary data and the clinical expertise of designated frontline workers who are involved in taking care of the patients during the pandemic.
According to the NIH press release, the guidelines consider two broad categories of therapies currently in use by healthcare providers for COVID-19: antivirals, which may target the coronavirus directly, and host modifiers and immune-based therapies, which may influence the immune response to the virus or target the virus.
The guidelines provide background information about each agent—such as clinical data about its use, ongoing clinical trials, and known interactions with other drugs—that forms the basis for the Recommendation.
The guidelines explain the evaluation and stratification of patients based on their risk of infection and severity of illness. For example, patients who are either asymptomatic or who have mild to moderate symptoms, patients who are severely ill. Special considerations for pregnant women and for children who are infected are also included.
Also Read: Centre should facilitate return of stranded migrant labourers to their homes: Mayawati
